Lomotil (Diphenoxylate) in Pregnancy: FDA Category C Risks and Safer Alternatives

FDA Pregnancy Category C

Animal studies show adverse fetal effects; no adequate human studies. Potential benefits may warrant use despite risks, but generally avoided.

Specific Concerns

  • Diphenoxylate is an opioid congener (meperidine derivative); crosses placenta.
  • Atropine component (subtherapeutic to deter abuse) – anticholinergic effects.
  • First trimester: Theoretical teratogenicity; animal data show malformations at high doses.
  • Late pregnancy: Neonatal opioid withdrawal (respiratory depression, hypotonia, feeding difficulty).
  • Constipation: Worsens common pregnancy complaint.

Safer Alternatives for Diarrhea in Pregnancy

  • Loperamide (Imodium): Preferred opioid agonist; minimal CNS penetration; Category B (animal studies no risk). Short-term use generally accepted.
  • Oral rehydration solution (ORS): WHO formula; replaces fluids/electrolytes.
  • Dietary: BRAT diet (bananas, rice, applesauce, toast), soluble fiber (psyllium), probiotics (L. rhamnosus GG, S. boulardii).
  • Bismuth subsalicylate (Pepto-Bismol): Avoid – salicylate component (Category C/D in 3rd trimester).

When to See a Provider

  • Bloody diarrhea, fever >38°C, severe abdominal pain, signs of dehydration, >6 loose stools/24 hr.
  • Underlying IBD, IBS, or medication-induced diarrhea.

Bottom Line

Avoid Lomotil in pregnancy. Use loperamide short-term if needed, prioritize hydration, and consult your OB for persistent symptoms.

Pregnancy & Health - Related Articles